What we do Panjon Limited manufactures and trades consumer and pharmaceutical products, including renowned brands like Panjon Tablet and Balm, and has diversified into realty and medical waste management. |
Founded in 1,990 |
Market share Established market presence with a wide distributor network across India and growing international negotiations. |
Problem solved Provides accessible healthcare and consumer wellness products, and now manages medical bi-product waste. |
Top clients or who we serve B2C customers across India with presence in local markets; seeking expansion into Gulf, Asian countries, UK, and US. |
Key management - |
Our journey and innovations Started as pharma and consumer product maker, expanded product range continually, entered realty, and recently ventured into medical waste management. |
Where we operate Pan-India presence with distributors; export markets under development including Gulf and Western countries. |
Top products or what we offer Panjon Tablet, Balm, Inhaler, Cough Drops, Swad Digestive and Chyawanpra Candies; recently diversified into real estate and medical waste services. |
Top brands Panjon Tablet and Balm (well-known consumer brands), Swad range (digestive and candies). |
Raw materials needed Pharmaceutical ingredients and consumer product raw materials. |
Raw materials supplier Not specified |
Recurring vs cyclical contribution Mix of recurring sales from established consumer products and emerging real estate and medical waste management revenues. |
Our industry position Recognized in pharmaceutical consumer segment with ongoing diversification to mitigate market slowdown risks. |
Financial highlights Revenue surged 142% to Rs. 30.46 Crore in 2024-25; profit before tax rose 235% to Rs. 0.53 Crore; earnings per share Rs. 0.234. |
Geographical revenue split Major revenue from Central India (approx. 27.56 Cr), followed by West, Export, and minor from other Indian regions. |
Order book - |
Whats driving growth Growth driven by product range expansion, diversification into realty, and entry into medical waste management amid market slowdowns. |
Our future plans Expand distribution internationally, diversify consumer product ranges, and strengthen new business segments such as waste management and realty. |
Our green promise Focused on energy conservation, renewable energy use, waste minimization, and health and safety compliance in operations. |
Our people and values Committed to inclusivity, employee development, well-being, and fostering collaborative workplace culture. |
Key challenges ahead Market slowdown, rising costs in realty segment, and scaling medical waste management business amid competition. |
Interesting facts Transitioned from consumer pharma to real estate and medical waste management; notable product launches include TOM IMLI and PURTI TAZGI MASALA. |
Risks and strategy Managing market volatility by diversifying business lines; robust risk assessments guided by Audit Committee and continuous Board oversight. |
